Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
LIPOSCIENCE INC (LPDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/17/2015 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 0% stake in LipoScience, Inc. |
| 02/17/2015 |
SC 13G/A
| Flynn James E reports a 0% stake in LipoScience, Inc. |
| 02/12/2015 |
SC 13G
| SightLine Healthcare Management III, L.P. reports a 0% stake in LipoScience, Inc. |
| 02/12/2015 |
SC 13G/A
| GARDNER LEWIS ASSET MANAGEMENT L P reports a 0% stake in LipoScience Inc |
| 11/25/2014 |
8-K/A
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits |
| 11/24/2014 |
SC 13D/A
| LABORATORY CORP OF AMERICA HOLDINGS reports a 100% stake in LipoScience, Inc. |
| 11/24/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/24/2014 |
4
| Young Roderick A (Director) has filed a Form 4 on LIPOSCIENCE INC |
| 11/24/2014 |
4
| Twiddy Kathryn (VP, General Counsel, Secretary) has filed a Form 4 on LIPOSCIENCE INC |
| 11/24/2014 |
4
| Otvos James D. (EVP, Chief Scientific Officer) has filed a Form 4 on LIPOSCIENCE INC |
| 11/24/2014 |
4
| McDonald E. Duffy (Vice President, HR) has filed a Form 4 on LIPOSCIENCE INC |
| 11/24/2014 |
4
| Martindale Lucy G. (EVP and CFO) has filed a Form 4 on LIPOSCIENCE INC |
| 11/24/2014 |
4
| LEVANGIE DANIEL J (Director) has filed a Form 4 on LIPOSCIENCE INC|
Txns:
| Disposed/sold 10,077 shares
@ $5.25, valued at
$52.9k
Disposed/sold 10,000 shares
@ $5.25, valued at
$52.5k
|
|
| 11/24/2014 |
4
| HURLEY JAMES R (Director) has filed a Form 4 on LIPOSCIENCE INC|
Txns:
| Disposed/sold 12,670 shares
@ $5.25, valued at
$66.5k
Disposed/sold 5,100 shares
@ $5.25, valued at
$26.8k
|
|
| 11/24/2014 |
4
| HILLDALE PHILIP D (Vice President of Sales) has filed a Form 4 on LIPOSCIENCE INC|
Txns:
| Granted 60,000 shares
@ $0
Disposed/sold 80,250 shares
@ $5.25, valued at
$421.3k
|
|
| 11/24/2014 |
4
| Greczyn Robert J Jr (Director) has filed a Form 4 on LIPOSCIENCE INC|
Txns:
| Disposed/sold 18,046 shares
@ $5.25, valued at
$94.7k
Disposed/sold 10,000 shares
@ $5.25, valued at
$52.5k
Disposed/sold 47,807 options to buy
@ $5.07, valued at
$242.4k
|
|
| 11/24/2014 |
4
| Doran Howard JR (President and CEO) has filed a Form 4 on LIPOSCIENCE INC|
Txns:
| Disposed/sold 52,884 shares
@ $5.25, valued at
$277.6k
Disposed/sold 317,306 options to buy
@ $4.16, valued at
$1.3M
|
|
| 11/24/2014 |
4
| CROMWELL WILLIAM C (Chief Medical Officer) has filed a Form 4 on LIPOSCIENCE INC|
Txns:
| Disposed/sold 21,456 shares
@ $5.25, valued at
$112.6k
|
|
| 11/24/2014 |
4
| Benson Buzz (Director) has filed a Form 4 on LIPOSCIENCE INC |
| 11/24/2014 |
4
| Barber Jeffrey T (Director) has filed a Form 4 on LIPOSCIENCE INC|
Txns:
| Disposed/sold 12,135 shares
@ $5.25, valued at
$63.7k
|
|
| 11/21/2014 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 11/12/2014 |
10-Q
| Quarterly Report for the period ended September 30, 2014 |
| 11/12/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 11/12/2014 |
8-K
| Quarterly results |
| 11/10/2014 |
SC 13G
| GARDNER LEWIS ASSET MANAGEMENT L P reports a 16.5% stake in LipoScience Inc |
| 11/10/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 10/27/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 10/20/2014 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 10/15/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 10/15/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 10/03/2014 |
SC 13D
| LABORATORY CORP OF AMERICA HOLDINGS reports a 17.7% stake in LipoScience, Inc. |
| 09/26/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 09/25/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 09/25/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
|
|